NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-160-2009-2-EP-04 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis EP National Stage 09795720.3 Abandoned
NINDS E-160-2009-2-AT-08 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis AT EP 09795720.3 Abandoned
NINDS E-160-2009-2-BE-09 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis BE EP 09795720.3 Abandoned
NINDS E-160-2009-2-BG-10 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis BG EP 09795720.3 Abandoned
NINDS E-160-2009-2-SI-39 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SI EP 09795720.3 Abandoned
NINDS E-160-2009-2-ES-17 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis ES EP 09795720.3 Abandoned
NINDS E-160-2009-2-SM-41 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SM EP 09795720.3 Abandoned
NINDS E-160-2009-2-RO-37 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis RO EP 09795720.3 Abandoned
NINDS E-160-2009-2-SE-38 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SE EP 09795720.3 Abandoned
NINDS E-160-2009-2-PL-35 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis PL EP 09795720.3 Abandoned
NINDS E-160-2009-2-NO-34 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis NO EP 09795720.3 Abandoned
NINDS E-160-2009-2-PT-36 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis PT EP 09795720.3 Abandoned
NINDS E-160-2009-2-SK-40 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis SK EP 09795720.3 Abandoned
NINDS E-160-2009-2-MK-31 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MK EP 09795720.3 Abandoned
NINDS E-160-2009-2-FI-18 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis FI EP 09795720.3 Abandoned
NINDS E-160-2009-2-FR-19 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis FR EP 09795720.3 Abandoned
NINDS E-160-2009-2-DE-14 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis DE EP 09795720.3 Abandoned
NINDS E-160-2009-2-IT-25 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis IT EP 09795720.3 Abandoned
NINDS E-160-2009-2-IS-24 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis IS EP 09795720.3 Abandoned
NINDS E-160-2009-2-IE-23 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis IE EP 09795720.3 Abandoned
NINDS E-160-2009-2-HU-22 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis HU EP 09795720.3 Abandoned
NINDS E-160-2009-2-LV-29 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LV EP 09795720.3 Abandoned
NINDS E-160-2009-2-NL-33 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis NL EP 09795720.3 Abandoned
NINDS E-160-2009-2-LT-27 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LT EP 09795720.3 Abandoned
NINDS E-160-2009-2-LU-28 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LU EP 09795720.3 Abandoned
NINDS E-160-2009-2-MC-30 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MC EP 09795720.3 Abandoned
NINDS E-160-2009-2-MT-32 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MT EP 09795720.3 Abandoned
NINDS E-160-2009-2-LI-26 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis LI EP 09795720.3 Abandoned
NINDS E-160-2009-2-GB-20 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis GB EP 09795720.3 Abandoned
NINDS E-160-2009-2-CH-11 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis CH EP 09795720.3 Abandoned
NINDS E-160-2009-2-TR-42 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis TR EP 09795720.3 Abandoned
NINDS E-160-2009-2-AU-02 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis AU National Stage 2009345604 Abandoned
NINDS E-160-2009-2-MX-06 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis MX National Stage MX/A/2011/011494 Abandoned
NINDS E-160-2009-2-US-07 Quinone Derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis US National Stage 12/768,930 8347984 Abandoned PDF
NINDS E-160-2009-2-PCT-01 Quinone derivative 2, 3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis PCT PCT COMB PCT/EP2009/009148 Expired
NINDS E-160-2009-2-JP-05 Quinone Derivative 2,3-Dimethoxy-5-Methyl-6-(10-Hydroxydecyl)-1,4-Benzoquinone for the Treatment of Primary Progressive Multiple Sclerosis JP National Stage 2012-507605 Abandoned
NICHD E-016-1996-0-US-28 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS US DIV 12/641,172 8003629 Abandoned PDF
NIAID E-285-2002-0-JP-19 Lutzomyia Longipalpis Polypeptides and Methods of Use JP DIV 2009-285970 Abandoned
NINDS E-143-2002-1-JP-11 Method For the Treatment of Multiple Sclerosis JP DIV 2009-284862 Abandoned
NCI E-028-2007-0-US-08 Novel Insertion Sites In Pox Vectors US CON 12/639,781 Abandoned
NCI E-050-2010-0-US-01 Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL US 61/287,139 Abandoned
NCI E-141-2008-0-US-07 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof US National Stage 12/666,052 9931377 Issued PDF
NCI E-256-1999-0-US-15 Determination of AM-Binding Proteins and the Association of Adrenomedullin (AM) Therewith US DIV 12/638,747 7993857 Expired PDF
NICHD E-010-2010-0-US-01 Method For The Detection Of A Subdural Hematoma For Use In A Handheld Hematoma Detector And Discriminator. US 61/286,626 Abandoned
NINDS E-155-2006-0-US-07 Novel Neuroactive Steroids US National Stage 12/664,470 8575375 Issued PDF
NCI E-113-2003-0-AU-06 Target Activated Microtransfer AU DIV 2009250964 Expired
NCI E-200-2007-0-US-03 Inactivators Of 06-Alkylguanine-DNA Alkytransferase US National Stage 12/597,773 8188055 Issued PDF
NIAID E-249-2007-0-US-02 Cloned Genome of Infectious Hepatitis C Virus Strain HC-TN and Uses Thereof US DIV 12/637,696 Abandoned
NCATS E-268-2009-0-US-01 DELIVERY OF A THERAPEUTIC PROTEIN, TRANSTHYRETIN (TTR), ACROSS THE BLOOD-BRAIN BARRIER (BBB) AS A TREATMENT FOR ALZHEIMER'S DISEASE. US 61/286,205 Abandoned
NINDS E-007-2009-0-PCT-02 Agents That Selectively Inhibit CD25 On Dendritic Cells or T-cells And Their Use PCT PCT PCT/US2009/067755 Expired